|
 |
On November 2, 2005, a
long-awaited victory was achieved for people at risk for
Sickle Cell disease. Ontario became the first province in
Canada to include sickle cell in its expanded newborn
screening program, set to be initiated this March. Sickle
Cell anemia is a life-threatening and inherited disorder
that affects the normal functioning of the red blood cells.
The program will help to identify infants with the disorder
earlier so that they can get the treatment that they need as
soon as possible. Special thanks to the Sickle Cell
Association of Ontario and the countless individuals and
agencies who held meetings, wrote letters, made calls and
lobbied the government for change. For more information,
visit
www.sicklecellontario.com. |
| Look
online! At
www.blackwomanandchild.com, we have a new
Articles
section, upgraded
Subscriptions
services and the electronic version of
Mama’s Market
is finally open for business.
In our
Articles section, readers can see excerpts of
past articles, and download these articles for print in PDF
format – graphics and all! Get what you’ve missed or share
individual articles with your friends.
We now accept credit card
payments through PayPal for subscriptions, donations and
merchandise in our
Mama’s Market.
While supplies last, get a Black Mother = Power T-shirt for
$15.00 or FREE with a two-year subscription. |
Did
You Know? Health
Canada and the makers of the birth control shot Depo-Provera
are warning women that the injections are linked to bone
loss? According to the Calgary Herald, studies are showing
that, even in women as young as 25 years and teens as young
aged 12 to 18 years, the longer Depo-Provera is used, the
more bone density is lost, and this is often irreversible.
This bone loss can lead to osteoporosis (brittle bones) as
well as hip, wrist and other bone fractures. Bottom Line?
Don’t use it!
This past December, a
$700-million class action lawsuit was filed against Pfizer
Canada Inc., and Pfizer Inc. For more information about the
lawsuit and the risks of using this drug, visit
www.depoproveraclassaction.com. |